← All companies

BTCY

Biotricity, Inc.

BTCY OTC Surgical & Medical Instruments & Apparatus EDGAR ↗

$0.10

-0.01 -10.91%

Key statistics

from XBRL data in SEC filings

Market cap

$1.97M

Revenue (TTM)

$16.0M

Net income (TTM)

-$2.40M

EPS (TTM)

$-0.12

P/E ratio

—

Dividend yield

—

Free cash flow

-$749K

Cash

$150K

Total assets

$6.45M

Gross margin

80.9%

52-week range

$0.09 – $0.75

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-K Fiscal year ended 2026-03-31 Jul 14, 2026 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws May 1, 2026 8-K Results of operations (earnings release) Feb 18, 2026 10-Q Quarter ended 2025-12-31 Feb 11, 2026 8-K Results of operations (earnings release) Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-K/A Fiscal year ended 2025-03-31 Jul 18, 2025 10-K Fiscal year ended 2025-03-31 Jul 15, 2025 8-K Results of operations (earnings release) Feb 24, 2025 10-Q/A Quarter ended 2024-12-31 Feb 20, 2025 10-Q Quarter ended 2024-12-31 Feb 19, 2025 8-K Results of operations (earnings release) Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 10-Q Quarter ended 2024-06-30 Aug 19, 2024 8-K Shareholder vote results Aug 16, 2024 8-K Delisting notice or listing-rule failure Aug 7, 2024 8-K Delisting notice or listing-rule failure Aug 1, 2024 8-K Unregistered sale of equity; Other events Jul 16, 2024 8-K Shareholder vote results Jul 12, 2024 10-K/A Fiscal year ended 2024-03-31 Jun 28, 2024 10-K Fiscal year ended 2024-03-31 Jun 27, 2024 8-K Entered a material agreement; Unregistered sale of equity Jun 24, 2024 8-K Unregistered sale of equity Jun 7, 2024 8-K Entered a material agreement May 28, 2024 8-K Unregistered sale of equity; Other events May 21, 2024 8-K Delisting notice or listing-rule failure; Unregistered sale of equity; Other events May 3, 2024 8-K Delisting notice or listing-rule failure; Other events Apr 23, 2024 8-K Amended charter or bylaws; Shareholder vote results Apr 3, 2024 8-K Entered a material agreement; Unregistered sale of equity Mar 26, 2024 10-Q Quarter ended 2023-12-31 Feb 20, 2024 8-K Delisting notice or listing-rule failure Feb 2, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Nov 6, 2023 8-K Entered a material agreement; Amended charter or bylaws Sep 20, 2023 8-K Results of operations (earnings release) Aug 17, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Delisting notice or listing-rule failure Aug 4, 2023 8-K Other events Jul 20, 2023 8-K Results of operations (earnings release); Modified rights of security holders; Amended charter or bylaws; Other events Jul 5, 2023